Axya Medical raises $6.8m for arthroscopic development
This article was originally published in Clinica
Executive Summary
Beverly, Massachusetts-based Axya Medical has raised $6.8m from several venture capital firms led by The Vertical Group, of Summit, New Jersey. Axya president and CEO Paul Fenton said that the funds would be used to support expansion of sales and marketing, secure more distributors in the US and develop new products for the Axya Shoulder Fixation System used in arthroscopic shoulder procedures following sports or other injuries.
You may also be interested in...
STRENGTH Results May Weaken Chances For Omega-3 Fatty Acid Heart Health Claims
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
FDA To Combo Product Sponsors: Consider Traditional Pathways Before Asking For Meeting
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.
Conquering Metabesity: Expert Panel Discusses Roadmap To Find Solutions
Metabesity is a complex issue that will require a multi-disciplinary approach, concerted effort and clear regulatory pathway to achieve solutions.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: